Allogenetics
PrivateLast Round
Seed
Aug 29, 2024
Total Funding Raised
$3.77M
Momentum Score
25 /100
Company Overview
Allogenetics is a biotechnology company developing a therapeutic approach that treats a donor organ to prevent rejection by the recipient's immune system.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Government Contracts, Revenue Share
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Allogenetics Comps
Public and private peers based on sector, stage, and business model.
Allogenetics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Aug 29, 2024 |
Key People
Founding team and executive leadership
Allogenetics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| NBank Capital | Seed |
| CARMA FUND | Seed |
Allogenetics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Allogenetics's valuation, stock price, and market status.
